KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.61 Friday, 26th Apr 2024 CHRS stock ended at $2.04. This is 5.70% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.74% from a day low at $1.93 to a day high of $2.06.
90 days $1.91 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Apr 12, 2016 $21.58 $21.66 $20.59 $21.56 165 790
Apr 11, 2016 $22.29 $22.48 $21.52 $21.60 121 697
Apr 08, 2016 $22.87 $22.98 $21.68 $22.23 141 976
Apr 07, 2016 $23.53 $24.38 $22.37 $22.52 265 532
Apr 06, 2016 $22.78 $24.90 $22.77 $23.85 272 312
Apr 05, 2016 $21.77 $22.97 $21.51 $22.62 214 294
Apr 04, 2016 $22.50 $23.59 $20.84 $22.07 373 373
Apr 01, 2016 $20.97 $22.57 $20.60 $22.47 252 454
Mar 31, 2016 $19.41 $21.77 $19.41 $21.23 227 619
Mar 30, 2016 $20.01 $20.95 $19.38 $19.48 124 343
Mar 29, 2016 $18.89 $19.90 $18.12 $19.82 182 000
Mar 28, 2016 $19.54 $19.82 $18.47 $18.83 98 600
Mar 24, 2016 $19.01 $19.87 $18.29 $19.41 190 200
Mar 23, 2016 $19.99 $20.12 $18.83 $19.11 225 300
Mar 22, 2016 $20.00 $20.71 $19.87 $20.00 192 800
Mar 21, 2016 $19.07 $20.83 $19.07 $20.24 221 100
Mar 18, 2016 $18.57 $19.68 $18.09 $19.39 303 600
Mar 17, 2016 $18.21 $18.64 $17.01 $18.42 137 700
Mar 16, 2016 $18.22 $19.07 $17.69 $18.41 92 700
Mar 15, 2016 $19.78 $19.89 $18.05 $18.26 207 100
Mar 14, 2016 $19.12 $20.69 $19.12 $20.04 180 500
Mar 11, 2016 $18.28 $19.11 $18.22 $19.09 180 800
Mar 10, 2016 $19.44 $19.60 $17.58 $18.00 278 200
Mar 09, 2016 $19.29 $19.76 $17.94 $19.61 243 500
Mar 08, 2016 $19.84 $20.16 $18.07 $19.27 366 100
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT